By Adriano Marchese

 

Merck & Co. is set to expand its investigational antiviral drug in the treatment against Covid-19 in a manufacturing agreement with Thermo Fisher Scientific Inc.

In a statement on Monday, the pharmaceutical company said Thermo Fisher will manufacture molnupiravir in its site in Whitby, Ontario, for global distribution.

The news follows the signing of a supply agreement for the drug with the Canadian government on Friday.

 

Write to Adriano Marchese at adriano.marchese@wsj.com

 

(END) Dow Jones Newswires

December 06, 2021 11:24 ET (16:24 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Dec 2021 to Jan 2022 Click Here for more Thermo Fisher Scientific Charts.
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Jan 2021 to Jan 2022 Click Here for more Thermo Fisher Scientific Charts.